Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1985-11-14
1987-10-27
Kight, John
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 530350, 530352, 530395, 530825, 435 68, A61K 39104, C07K 1504
Patent
active
047029102
ABSTRACT:
PSC-A is a new serological common antigen to Pseudomonas aeruginosa having very low toxicity, and highly effective for protecting infection by any of the serotypes of Pseudomonas aeruginosa. PSC-A can be used as the active component in a pharmaceutical agent for protecting Pseudonomas aeruginosa infection.
REFERENCES:
patent: 4428931 (1984-01-01), Tolman et al.
patent: 4575459 (1986-03-01), Homma et al.
patent: 4578458 (1986-03-01), Pier
Fukuda Tamotsu
Kuroiwa Yasuyuki
Okuya Hiroaki
Shigeta Shiro
Sudo Tadashi
Draper Garnette D.
Kight John
Mitsui Toatsu Chemicals Inc.
LandOfFree
Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1271377